The company’s adjusted earnings per share for the quarter were $12.58, above the average analyst estimate of $11 per share. It boosted its adjusted profit expectations for the year to $26.75 per share. Both figures include about $1 per share of non-recurring net investment income, Elevance said in a
Medical costs were modestly lower than the company expected in the ...
